Pharmacology & Pharmacy 期刊：按影响因子、JCR 分区与中科院分区浏览 Web of Science「Pharmacology & Pharmacy」学科，并核对索引收录。共 359 种期刊，按影响因子排序。
按影响因子降序展示前 100 / 共 359 种期刊（字段与主站一致：IF · JCR · 中科院 · 索引 · 出版商）。
| # | 期刊 | 影响因子 | JCR 分区 | 中科院 | 索引 | 出版商 |
|---|---|---|---|---|---|---|
| 1 | NATURE REVIEWS DRUG DISCOVERY | 91.2 | Q1 | 1区 | SCIE | NATURE PORTFOLIO |
| 2 | TRENDS IN PHARMACOLOGICAL SCIENCES | 24 | Q1 | 1区 | SCIE | CELL PRESS |
| 3 | DRUG RESISTANCE UPDATES | 22 | Q1 | 1区 | SCIE | CHURCHILL LIVINGSTONE |
| 4 | ADVANCED DRUG DELIVERY REVIEWS | 21 | Q1 | 1区 | SCIE, EI | ELSEVIER |
| 5 | PHARMACOLOGICAL REVIEWS | 20.3 | Q1 | 1区 | SCIE | ELSEVIER |
| 6 | ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 19 | Q1 | 1区 | SCIE | ANNUAL REVIEWS |
| 7 | DRUGS | 14.7 | Q1 | 1区 | SCIE | ADIS INT LTD |
| 8 | ACTA PHARMACEUTICA SINICA B | 14.6 | Q1 | 1区 | SCIE | INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES |
| 9 | MEDICINAL RESEARCH REVIEWS | 13.6 | Q1 | 1区 | SCIE | WILEY |
| 10 | PHARMACOLOGY & THERAPEUTICS | 13.5 | Q1 | 1区 | SCIE | PERGAMON-ELSEVIER SCIENCE LTD |
| 11 | ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 12.6 | Q1 | 1区 | SCIE | KEAI PUBLISHING LTD |
| 12 | JOURNAL OF CONTROLLED RELEASE | 12.4 | Q1 | 1区 | SCIE, EI | ELSEVIER |
| 13 | PHARMACOLOGICAL RESEARCH | 12.2 | Q1 | 2区 | SCIE | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| 14 | PHYTOMEDICINE | 11.3 | Q1 | 1区 | SCIE | ELSEVIER GMBH |
| 15 | JOURNAL OF PHARMACEUTICAL ANALYSIS | 11.2 | Q1 | 1区 | SCIE | ELSEVIER |
| 16 | ACTA PHARMACOLOGICA SINICA | 10.4 | Q1 | 2区 | SCIE | NATURE PUBL GROUP |
| 17 | DRUG DISCOVERY TODAY | 8.7 | Q1 | 2区 | SCIE | ELSEVIER SCI LTD |
| 18 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 8.7 | Q1 | 2区 | SCIE | DOVE MEDICAL PRESS LTD |
| 19 | BIODRUGS | 8.5 | Q1 | 2区 | SCIE | ADIS INT LTD |
| 20 | ARCHIVES OF PHARMACAL RESEARCH | 8.2 | Q1 | 2区 | SCIE | PHARMACEUTICAL SOC KOREA |
| 21 | EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 8.2 | Q1 | 2区 | SCIE | OXFORD UNIV PRESS |
| 22 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | 8.1 | Q1 | 2区 | SCIE | ELSEVIER |
| 23 | PHYTOTHERAPY RESEARCH | 8.1 | Q1 | 2区 | SCIE | WILEY |
| 24 | DRUG DELIVERY | 8 | Q1 | 2区 | SCIE | TAYLOR & FRANCIS LTD |
| 25 | INTERNATIONAL JOURNAL OF PHARMACEUTICS-X | 7.9 | Q1 | 2区 | SCIE | ELSEVIER |
| 26 | NEUROPSYCHOPHARMACOLOGY | 7.6 | Q1 | 2区 | SCIE | SPRINGERNATURE |
| 27 | BIOMEDICINE & PHARMACOTHERAPY | 7.5 | Q1 | 2区 | SCIE | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
| 28 | BRITISH JOURNAL OF PHARMACOLOGY | 7.5 | Q1 | 2区 | SCIE | WILEY |
| 29 | CHINESE JOURNAL OF NATURAL MEDICINES | 7.5 | Q1 | 2区 | SCIE | CHINESE JOURNAL NATURAL MEDICINES |
| 30 | CHINESE MEDICINE | 7.4 | Q1 | 2区 | SCIE | BMC |
| 31 | NEUROTHERAPEUTICS | 7.4 | Q1 | 2区 | SCIE | ELSEVIER SCIENCE INC |
| 32 | EXPERT OPINION ON DRUG DISCOVERY | 7.3 | Q1 | 2区 | SCIE | TAYLOR & FRANCIS LTD |
| 33 | CURRENT MOLECULAR PHARMACOLOGY | 7.2 | Q1 | 4区 | SCIE | KEAI PUBLISHING LTD |
| 34 | CNS DRUGS | 7 | Q1 | 1区 | SCIE | ADIS INT LTD |
| 35 | DRUG DELIVERY AND TRANSLATIONAL RESEARCH | 6.9 | Q1 | 3区 | SCIE | SPRINGER HEIDELBERG |
| 36 | JOURNAL OF CLINICAL LIPIDOLOGY | 6.9 | Q1 | 3区 | SCIE | ELSEVIER SCIENCE INC |
| 37 | PHARMACEUTICS | 6.9 | Q1 | 3区 | SCIE | MDPI |
| 38 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 6.8 | Q1 | 1区 | SCIE | WILEY |
| 39 | CLINICAL AND EXPERIMENTAL HYPERTENSION | 6.8 | Q1 | 4区 | SCIE | TAYLOR & FRANCIS INC |
| 40 | JOURNAL OF ETHNOPHARMACOLOGY | 6.8 | Q1 | 2区 | SCIE | ELSEVIER IRELAND LTD |
| 41 | CNS NEUROSCIENCE & THERAPEUTICS | 6.6 | Q1 | 2区 | SCIE | WILEY |
| 42 | BIOCHEMICAL PHARMACOLOGY | 6.5 | Q1 | 2区 | SCIE | PERGAMON-ELSEVIER SCIENCE LTD |
| 43 | LIFE SCIENCES | 6.4 | Q1 | 3区 | SCIE | PERGAMON-ELSEVIER SCIENCE LTD |
| 44 | CURRENT NEUROPHARMACOLOGY | 6.1 | Q1 | 3区 | SCIE | BENTHAM SCIENCE PUBL LTD |
| 45 | DRUG DESIGN DEVELOPMENT AND THERAPY | 6.1 | Q1 | 2区 | SCIE | DOVE MEDICAL PRESS LTD |
| 46 | JOURNAL OF NEUROIMMUNE PHARMACOLOGY | 6.1 | Q1 | 3区 | SCIE | SPRINGER |
| 47 | EXPERT OPINION ON DRUG DELIVERY | 6 | Q1 | 2区 | SCIE | TAYLOR & FRANCIS LTD |
| 48 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 6 | Q1 | 2区 | SCIE | ELSEVIER |
| 49 | PHARMACEUTICAL BIOLOGY | 6 | Q1 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 50 | DRUG SAFETY | 5.9 | Q1 | 2区 | SCIE | ADIS INT LTD |
| 51 | FRONTIERS IN DRUG DISCOVERY | 5.8 | Q1 | — | ESCI | FRONTIERS MEDIA SA |
| 52 | MOLECULAR DIAGNOSIS & THERAPY | 5.8 | Q1 | 3区 | SCIE | ADIS INT LTD |
| 53 | EUROPEAN JOURNAL OF PHARMACOLOGY | 5.7 | Q1 | 3区 | SCIE | ELSEVIER |
| 54 | MARINE DRUGS | 5.7 | Q1 | 2区 | SCIE | MDPI |
| 55 | PHARMACEUTICALS | 5.7 | Q1 | 3区 | SCIE | MDPI |
| 56 | INTERNATIONAL IMMUNOPHARMACOLOGY | 5.6 | Q1 | 2区 | SCIE | ELSEVIER |
| 57 | ANTIBIOTICS-BASEL | 5.5 | Q1 | 3区 | SCIE | MDPI |
| 58 | CURRENT OPINION IN PHARMACOLOGY | 5.5 | Q1 | 3区 | SCIE | ELSEVIER SCI LTD |
| 59 | JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 5.5 | Q1 | 4区 | SCIE | FRONTIERS MEDIA SA |
| 60 | RSC PHARMACEUTICS | 5.5 | Q1 | — | ESCI | ROYAL SOC CHEMISTRY |
| 61 | FRONTIERS IN PHARMACOLOGY | 5.4 | Q1 | 3区 | SCIE | FRONTIERS MEDIA SA |
| 62 | JOURNAL OF PSYCHOPHARMACOLOGY | 5.3 | Q1 | 3区 | SCIE | SAGE PUBLICATIONS LTD |
| 63 | CHEMICO-BIOLOGICAL INTERACTIONS | 5.2 | Q1 | 2区 | SCIE | ELSEVIER IRELAND LTD |
| 64 | JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | 5.2 | Q1 | 3区 | SCIE | ELSEVIER |
| 65 | TOXICOLOGY | 5.2 | Q1 | 3区 | SCIE | ELSEVIER IRELAND LTD |
| 66 | AAPS PHARMSCITECH | 5.1 | Q1 | 4区 | SCIE | SPRINGER |
| 67 | ADMET AND DMPK | 5.1 | Q1 | 4区 | ESCI | IAPC PUBLISHING |
| 68 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 5.1 | Q1 | 3区 | SCIE | ELSEVIER |
| 69 | EXPERT OPINION ON THERAPEUTIC TARGETS | 5.1 | Q1 | 2区 | SCIE | TAYLOR & FRANCIS LTD |
| 70 | JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE | 5.1 | Q1 | 2区 | SCIE | BMC |
| 71 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 5 | Q1 | 3区 | SCIE | ELSEVIER |
| 72 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 5 | Q1 | 2区 | SCIE | ELSEVIER |
| 73 | PSYCHEDELIC MEDICINE | 5 | Q1 | — | ESCI | SAGE PUBLICATIONS INC |
| 74 | THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 5 | Q1 | 3区 | SCIE | SAGE PUBLICATIONS LTD |
| 75 | BIOMOLECULES & THERAPEUTICS | 4.9 | Q1 | 4区 | SCIE | KOREAN SOC APPLIED PHARMACOLOGY |
| 76 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 4.9 | Q1 | 2区 | SCIE | WILEY |
| 77 | MOLECULAR PHARMACEUTICS | 4.9 | Q1 | 2区 | SCIE | AMER CHEMICAL SOC |
| 78 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 4.8 | Q1 | 2区 | SCIE | OXFORD UNIV PRESS |
| 79 | ADVANCED PHARMACEUTICAL BULLETIN | 4.7 | Q1 | 4区 | ESCI | TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES |
| 80 | ADVANCES IN THERAPY | 4.7 | Q1 | 3区 | SCIE | SPRINGER |
| 81 | DRUG METABOLISM REVIEWS | 4.7 | Q1 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 82 | EXPERT OPINION ON THERAPEUTIC PATENTS | 4.7 | Q1 | 2区 | SCIE | TAYLOR & FRANCIS LTD |
| 83 | JOURNAL OF DRUG TARGETING | 4.7 | Q1 | 4区 | SCIE | TAYLOR & FRANCIS LTD |
| 84 | JOURNAL OF LIPOSOME RESEARCH | 4.7 | Q1 | 4区 | SCIE | TAYLOR & FRANCIS LTD |
| 85 | JOURNAL OF PHARMACEUTICAL INVESTIGATION | 4.7 | Q1 | 3区 | SCIE | SPRINGERNATURE |
| 86 | NEUROPHARMACOLOGY | 4.7 | Q1 | 2区 | SCIE | PERGAMON-ELSEVIER SCIENCE LTD |
| 87 | PHARMACEUTICAL MEDICINE | 4.7 | Q1 | 4区 | ESCI | SPRINGER INT PUBL AG |
| 88 | PHARMACOECONOMICS | 4.7 | Q1 | 3区 | SCIE, SSCI | ADIS INT LTD |
| 89 | ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY | 4.6 | Q1 | 3区 | SCIE | ELSEVIER |
| 90 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 4.6 | Q1 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 91 | BIOMEDICINES | 4.5 | Q2 | 3区 | SCIE | MDPI |
| 92 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 4.5 | Q1 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 93 | FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES | 4.5 | Q2 | 4区 | ESCI | SPRINGER |
| 94 | PHARMACOLOGICAL REPORTS | 4.5 | Q2 | 4区 | SCIE | SPRINGER HEIDELBERG |
| 95 | FRONTIERS IN DRUG DELIVERY | 4.4 | Q2 | — | ESCI | FRONTIERS MEDIA SA |
| 96 | ANTIVIRAL RESEARCH | 4.3 | Q1 | 2区 | SCIE | ELSEVIER |
| 97 | AUSTRALIAN PRESCRIBER | 4.3 | Q2 | 2区 | ESCI | THERAPEUTIC GUIDELINES LTD |
| 98 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 4.3 | Q2 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 99 | EXPERT REVIEW OF NEUROTHERAPEUTICS | 4.3 | Q1 | 3区 | SCIE | TAYLOR & FRANCIS LTD |
| 100 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 4.3 | Q2 | 3区 | SCIE | ELSEVIER |